Nanvuranlat
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Nanvuranlat, covering 2026-04-09 to 2026-04-09. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer [Phase 3]